Expanding role of lenalidomide in hematologic malignancies
Nilanjan Ghosh, Michael R Grunwald, Omotayo Fasan, Manisha Bhutani Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA Abstract: Lenalidomide is an immunomodulatory agent that has been approved by the US Food and Drug Administration for treatment of multiple myeloma, deletion 5...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2015-05-01
|
| Серии: | Cancer Management and Research |
| Online-ссылка: | http://www.dovepress.com/expanding-role-of-lenalidomide-in-hematologic-malignancies-peer-reviewed-article-CMAR |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|